Proscia
Software DevelopmentPennsylvania, United States51-200 Employees
Proscia is fighting cancer with intelligent software that changes the way the world practices pathology. Join us.
Recent Funding Proscia has recently received a significant investment of $50M in funding, indicating strong financial backing to support potential sales opportunities.
Partnership Expansion Proscia has been actively expanding partnerships, such as the collaboration with Nucleai Inc. to enhance precision medicine, providing avenues for joint sales initiatives.
Industry Recognition Proscia's Concentriq AP-Dx has received FDA clearance, boosting credibility in the market and opening doors for sales to organizations seeking reliable pathology solutions.
Market Integration The partnership with MindPeak GmbH to integrate CE-IVD algorithms with Proscia's software platform demonstrates adaptability to market trends, offering sales opportunities in cutting-edge technologies.
Competitive Landscape Proscia's positioning alongside similar companies like DNAnexus and Tempus, both with substantial revenue figures, indicates potential for Proscia to capture market share and drive sales growth.
Proscia uses 8 technology products and services including Avalara, Coinbase, Kubernetes, and more. Explore Proscia's tech stack below.
Proscia Email Formats | Percentage |
First.Last@proscia.com | 80% |
Last@proscia.com | 10% |
First@proscia.com | 9% |
FL@proscia.com | 1% |
Software DevelopmentPennsylvania, United States51-200 Employees
Proscia is fighting cancer with intelligent software that changes the way the world practices pathology. Join us.
Proscia has raised a total of $50M of funding over 8 rounds. Their latest funding round was raised on Mar 19, 2025 in the amount of $50M.
Proscia's revenue is in the range of $10M$50M
Proscia has raised a total of $50M of funding over 8 rounds. Their latest funding round was raised on Mar 19, 2025 in the amount of $50M.
Proscia's revenue is in the range of $10M$50M